Home

konkurencija Njega snorkel ara c Karijera Memo Prosvetlite

Cytarabine (Cytosine β-D-arabinofuranoside) | DNA Synthesis Inhibitor |  MedChemExpress
Cytarabine (Cytosine β-D-arabinofuranoside) | DNA Synthesis Inhibitor | MedChemExpress

Rooster© | ARA-C Plus 20/5
Rooster© | ARA-C Plus 20/5

Rooster© | ARA-C 40
Rooster© | ARA-C 40

Cytarabine
Cytarabine

Cytarabine - Wikipedia
Cytarabine - Wikipedia

AraC - drug review: dosage, side effects, action, buy AraC
AraC - drug review: dosage, side effects, action, buy AraC

Structures of gemcitabine and ara-C (cytarabine). | Download Scientific  Diagram
Structures of gemcitabine and ara-C (cytarabine). | Download Scientific Diagram

Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell  death | BMC Cancer | Full Text
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text

Ara-C metabolism. Ara-C: Cytarabine; Ara-CDP: Ara-C diphosphate;... |  Download Scientific Diagram
Ara-C metabolism. Ara-C: Cytarabine; Ara-CDP: Ara-C diphosphate;... | Download Scientific Diagram

The effects of cytarabine combined with ginsenoside compound K  synergistically induce DNA damage in acute myeloid leukemia cells -  ScienceDirect
The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells - ScienceDirect

Cytarabine (1-β-D-Arabinofuranosylcytosine, NSC 63878, NSC 287459,  U-19920A, CAS Number: 147-94-4) | Cayman Chemical
Cytarabine (1-β-D-Arabinofuranosylcytosine, NSC 63878, NSC 287459, U-19920A, CAS Number: 147-94-4) | Cayman Chemical

Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used  in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia  (AL Stock Vector Image & Art - Alamy
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (AL Stock Vector Image & Art - Alamy

Valproic acid enhances the antileukemic effect of cytarabine by triggering  cell apoptosis
Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis

Phase I and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid  derivative of cytarabine, in adults with refractory hematological  malignancies | Leukemia
Phase I and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies | Leukemia

Valproic acid enhances the antileukemic effect of cytarabine by triggering  cell apoptosis
Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis

Neurotoxicity of cytarabine (Ara-C) in dorsal root ganglion neurons  originates from impediment of mtDNA synthesis and compromise of  mitochondrial function - ScienceDirect
Neurotoxicity of cytarabine (Ara-C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function - ScienceDirect

Farmacia San Antonio
Farmacia San Antonio

Sea to Ara C: Appendix
Sea to Ara C: Appendix

Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity  enhancing cytarabine efficacy | EMBO Molecular Medicine
Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine

Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose  Cytarabine through the Metabolic Perturbations of Ribonucleotide and  Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells | HTML
Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells | HTML

13191-15-6, Ara-C triphosphate, CAS No 13191-15-6 Ara-C triphosphate
13191-15-6, Ara-C triphosphate, CAS No 13191-15-6 Ara-C triphosphate

Metabolic pathway of ara-C | Download Scientific Diagram
Metabolic pathway of ara-C | Download Scientific Diagram

Structural basis for polymerase η–promoted resistance to the anticancer  nucleoside analog cytarabine | Scientific Reports
Structural basis for polymerase η–promoted resistance to the anticancer nucleoside analog cytarabine | Scientific Reports